Mesoblast lifts off as FDA agrees to review GvHD drug again

More than two years after Mesoblast was poleaxed by the FDA’s rejection of its mesenchymal stem cell therapy for children with graft versus host disease (GvHD), the US reg

Restructuring announced at ReNeuron as another CEO resigns

Catherine Isted has stepped down as chief executive of UK biotech ReNeuron with immediate effect, with board member and biopharma industry veteran Iain Ross appointed as executive chairman

Stem cell therapy 'cures' first woman with HIV, say research...

A woman with HIV who received a stem cell transplant to treat acute myeloid leukaemia (AML) appears to have been cured of the infection according to US researchers.

Novo Nordisk crowns cell therapy pipeline with $598m Heartse...

Novo Nordisk is paying $55 million upfront to secure rights to a cell therapy for heart failure developed by Japanese startup Heartseed.

Stem cell transplant eradicates HIV in second patient

Vertex looks beyond cystic fibrosis with $950m Semma buy